APA

Stratmann J., van Kann E., Rummelt C., Koschade S., Röllig C., Lübbert M., Schaich M., Parmentier S., Sebastian M., Chromik J., Becker von Rose A., Ballo O., Steffen B., Serve H., Brandts C. & Shaid S. (20200526). Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure. : Leukemia research.

Chicago

Stratmann Jan, van Kann Elisabeth, Rummelt Christoph, Koschade Sebastian, Röllig Christoph, Lübbert Michael, Schaich Markus, Parmentier Stefani, Sebastian Martin, Chromik Joerg, Becker von Rose Aaron, Ballo Olivier, Steffen Björn, Serve Hubert, Brandts Christian and Shaid Shabnam. 20200526. Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure. : Leukemia research.

Harvard

Stratmann J., van Kann E., Rummelt C., Koschade S., Röllig C., Lübbert M., Schaich M., Parmentier S., Sebastian M., Chromik J., Becker von Rose A., Ballo O., Steffen B., Serve H., Brandts C. and Shaid S. (20200526). Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure. : Leukemia research.

MLA

Stratmann Jan, van Kann Elisabeth, Rummelt Christoph, Koschade Sebastian, Röllig Christoph, Lübbert Michael, Schaich Markus, Parmentier Stefani, Sebastian Martin, Chromik Joerg, Becker von Rose Aaron, Ballo Olivier, Steffen Björn, Serve Hubert, Brandts Christian and Shaid Shabnam. Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure. : Leukemia research. 20200526.